Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

52-week Open Label Safety-Tolerability StudyRecruiting
NCT07369154Phase 3Updated Jul 27, 2026
Sponsor: LB Pharmaceuticals Inc.
Schizophrenia
United States
Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDSRecruiting
NCT05814432Phase 3Updated Jul 27, 2026
Sponsor: Federal University of Health Science of Porto Alegre
Disseminated Histoplasma Capsulatum Infection · AIDS and Infections · Immunosuppression · Fungal Infection
Brazil
A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With SchizophreniaRecruiting
NCT06882785Phase 3Updated Jul 27, 2026
Sponsor: Bristol-Myers Squibb
Schizophrenia
Japan
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.Recruiting
NCT04777357Phase 3Updated Jul 27, 2026
Sponsor: AbbVie
Depression · Bipolar I Disorder
United States, Puerto Rico, Russia
Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)Recruiting
NCT06577519Phase 3Updated Jul 27, 2026
Sponsor: Jiangsu vcare pharmaceutical technology co., LTD
Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
China
DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 InfectionRecruiting
NCT06203132Phase 3Updated Jul 27, 2026
Sponsor: ANRS, Emerging Infectious Diseases
HIV-1-infection
Brazil, Cameroon, Côte d’Ivoire, France, Mozambique +1 more
Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic DermatitisRecruiting
NCT06723080Phase 3Updated Jul 27, 2026
Sponsor: Jiangsu vcare pharmaceutical technology co., LTD
Moderate to Severe Atopic Dermatitis
China
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASHRecruiting
NCT07221188Phase 3Updated Jul 27, 2026
Sponsor: GlaxoSmithKline
Non-alcoholic Fatty Liver Disease
United States, Hong Kong
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint InRecruiting
NCT06745908Phase 3Updated Jul 27, 2026
Sponsor: ImmunityBio, Inc.
NSCLC Stage IV
United States, Canada, United Kingdom
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I DisorderRecruiting
NCT06951698Phase 3Updated Jul 27, 2026
Sponsor: Bristol-Myers Squibb
Bipolar-I Disorder With Mania or Mania With Mixed Features
United States, Argentina, Australia, Bulgaria, Hungary +4 more
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia GravisRecruiting
NCT04951622Phase 3Updated Jul 27, 2026
Sponsor: Janssen Research & Development, LLC
Myasthenia Gravis
United States, Australia, Belgium, Canada, China +12 more
Oxytocin vs Prostaglandins for Labor Induction of Women With an Unfavorable Cervix After 24h of Cervical RipeningRecruiting
NCT04949633Phase 3Updated Jul 27, 2026
Sponsor: University Hospital, Tours
Cervical Ripening · Unfavorable Cervix
France
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III TrialRecruiting
NCT06593431Phase 3Updated Jul 27, 2026
Sponsor: M.D. Anderson Cancer Center
Pancreas Cancer · Oligometastatic
United States
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute SchizophreniaRecruiting
NCT07363577Phase 3Updated Jul 27, 2026
Sponsor: LB Pharmaceuticals Inc.
Schizophrenia
United States
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast CancerRecruiting
NCT07205822Phase 3Updated Jul 27, 2026
Sponsor: AstraZeneca
Breast Cancer
United States, China, France, Italy, South Korea +1 more
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationRecruiting
NCT06647498Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Washington University School of Medicine
Alzheimers Disease · Dementia · Alzheimers Disease, Familial
United States, Argentina, Australia, Canada, Colombia +10 more
Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal MetastasesRecruiting
NCT06173401Phase 3Updated Jul 27, 2026
Sponsor: Stanford University
Spinal Metastases
United States
A Study Comparing BL-B01D1 Combined With Tislelizumab Versus Platinum-containing Chemotherapy Combined With Tislelizumab as First-line Treatment in Patients With Extensive-stage Small Cell Lung Cancer(PANKU-Lung07)Recruiting
NCT07502300Phase 3Updated Jul 27, 2026
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Extensive-stage Small-cell Lung Cancer
China
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)Recruiting
NCT06095583Phase 3Updated Jul 27, 2026
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Limited-stage Small Cell Lung Cancer (LS-SCLC)
China, Georgia, Netherlands, Spain, Taiwan +1 more
A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With SeizuresRecruiting
NCT04715646Phase 3Updated Jul 27, 2026
Sponsor: UCB Biopharma SRL
Epilepsy
United States, Belgium, Czechia, France, Germany +6 more
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary DiseaseRecruiting
NCT07363694Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Pfizer
Moderate to Severe Chronic Obstructive Pulmonary Disease
United States, Argentina, Canada, China, India +3 more
The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue MorbidityRecruiting
NCT06494878Phase 3Updated Jul 27, 2026
Sponsor: University of Calgary
Venous Thromboembolism · Postpartum Period · Aspirin · Low Molecular Weight Heparin
Belgium, Canada, Denmark, France, Ireland +2 more
VE303 for Prevention of Recurrent Clostridioides Difficile InfectionRecruiting
NCT06237452Phase 3Updated Jul 27, 2026
Sponsor: Vedanta Biosciences, Inc.
Clostridium Difficile · Clostridium Difficile Infections · Clostridium Difficile Infection Recurrence · Clostridioides Difficile Infection
United States, Australia, Belgium, Brazil, Bulgaria +19 more
Study of Yupingfeng Powder Treating Allergic Rhinitis (AR)Recruiting
NCT06608017Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Chinese University of Hong Kong
Allergic Rhinitis
Hong Kong
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationRecruiting
NCT05552157Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Washington University School of Medicine
Alzheimers Disease · Dementia · Alzheimers Disease, Familial
United States, Argentina, Australia, Canada, Colombia +10 more

Previous page Next page